Lakewood-Amedex Biotherapeutics Inc. (LABT)
CIK 2079272 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Lakewood-Amedex Biotherapeutics Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Aug 17, 2026 | 424B3 | 0001213900-26-090808 |
| Aug 14, 2026 | SCHEDULE 13G | 0001174947-26-000808 |
| Aug 14, 2026 | 10-Q | 0001213900-26-089380 |
| Aug 10, 2026 | DEF 14A | 0001213900-26-087336 |
| Aug 10, 2026 | DEFA14A | 0001213900-26-087338 |
| Aug 6, 2026 | SCHEDULE 13G | 0001213900-26-086054 |
| Jul 30, 2026 | PRE 14A | 0001213900-26-083353 |
| Jul 15, 2026 | 8-K | 0001213900-26-078328 |
| Jun 23, 2026 | SCHEDULE 13G | 0001213900-26-070922 |
| Jun 22, 2026 | 424B3 | 0001213900-26-070620 |
| Jun 22, 2026 | 424B3 | 0001213900-26-070622 |
| Jun 17, 2026 | 8-K | 0001213900-26-069512 |
| May 26, 2026 | 424B3 | 0001213900-26-061019 |
| May 26, 2026 | 424B3 | 0001213900-26-061018 |
| May 22, 2026 | 10-Q | 0001213900-26-060640 |
| May 14, 2026 | 424B4 | 0001213900-26-056648 |
| May 13, 2026 | EFFECT | 9999999995-26-001622 |
| May 6, 2026 | 3 | 0001193125-26-209578 |
| May 6, 2026 | 4 | 0001193125-26-209581 |
| May 1, 2026 | 3 | 0001213900-26-051053 |
| May 1, 2026 | 3 | 0001213900-26-051054 |
| May 1, 2026 | 3 | 0001213900-26-051078 |
| May 1, 2026 | 3 | 0001213900-26-051052 |
| May 1, 2026 | S-1 | 0001213900-26-050936 |
| Apr 30, 2026 | 424B3 | 0001213900-26-050264 |